Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution-Reference-Cited by-同舟云学术

Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Published:2019-08-08 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Florou Vaia^ORCID,Rosenberg Andrew E.,Wieder Eric,Komanduri Krishna V.,Kolonias Despina,Uduman Mohamed,Castle John C.,Buell Jennifer S.,Trent Jonathan C.,Wilky Breelyn A.

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0689-7.pdf

Reference31 articles.

1. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer. 1996;77:2400–6.

2. Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol. 2008;26:5269–74.

3. Florou V, Wilky BA. Current and future directions for Angiosarcoma therapy. Curr Treat Options in Oncol. 2018;19:14.

4. Lahat G, Dhuka AR, Hallevi H, et al. Angiosarcoma: clinical and molecular insights. Ann Surg. 2010;251:1098–106.

5. Sindhu S, Gimber LH, Cranmer L, McBride A, Kraft AS. Angiosarcoma treated successfully with anti-PD-1 therapy - a case report. J Immunother cancer. 2017;5:58.

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and immune pathobiology of human angiosarcoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy;eBioMedicine;2024-08

3. The challenge of running trials in advanced angiosarcoma: A systematic review of the literature from EORTC/STBSG to guide the development of angiosarcoma-specific trials;European Journal of Cancer;2024-08

4. PD-L1-Expression kutaner Angiosarkome;Die Chirurgie;2024-07-16

5. Angiosarcoma: clinical outcomes and prognostic factors, a single-center analysis;Journal of Cancer Research and Clinical Oncology;2024-06-25